New Delhi: There`s new hope for colorectal cancer (CRC) patients with the US FDA approving the first personalized therapy for its treatment. More than 42,000 new CRC are estimated to occur in India in 2012, doctors say.The FDA nod for Erbitux is based on data from a large scale patient study titled CRYSTAL (Cetuximab combined with iRinotecan in first-line therapY for metaSTatic colorectAL cancer) conducted outside the U.S, said an official release announcing the approval.
IAF`s Jaguar plane crashes in Kutch, pilot safe
Modi, Kerry discuss defence, terrorism
Aamir Khan poses naked in `PK` poster
Trilokpuri mishap: E-rickshaw driver arrested